PodParley PodParley
PodParley
Which patients might benefit the most from isatuximab-based combinations in the relapsed setting? episode artwork

EPISODE · Oct 2, 2022 · 3 MIN

Which patients might benefit the most from isatuximab-based combinations in the relapsed setting?

from Multiple Myeloma Hub

During the 19th International Myeloma Society Annual Meeting, the Multiple Myeloma Hub was pleased to speak to Roman Hájek, University of Ostrava, Ostrava, CZ. We asked, Which patients might benefit the most from isatuximab-based combinations in the relapsed setting?Hájek begins by explaining that isatuximab is an anti-CD38 monoclonal antibody currently approved for treatment in combination with pomalidomide + dexamethasone or carfilzomib + dexamethasone. This is followed by a discussion on why these combinations may be helpful for patients previously exposed or refractory to lenalidomide. Hosted on Acast. See acast.com/privacy for more information.

What this episode covers

During the 19th International Myeloma Society Annual Meeting, the Multiple Myeloma Hub was pleased to speak to Roman Hájek, University of Ostrava, Ostrava, CZ. We asked, Which patients might benefit the most from isatuximab-based combinations in the relapsed setting?Hájek begins by explaining that isatuximab is an anti-CD38 monoclonal antibody currently approved for treatment in combination with pomalidomide + dexamethasone or carfilzomib + dexamethasone. This is followed by a discussion on why these combinations may be helpful for patients previously exposed or refractory to lenalidomide. Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Which patients might benefit the most from isatuximab-based combinations in the relapsed setting?

0:00 3:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

Your Safety Net Has $1.17 In It and Your Vault Has No Lock

Apr 6, 2026 ·25m

The April 1st Rule and the Map They Already Made of Your Equity

Mar 30, 2026 ·27m

RAGA Texas Attorney General Debate Reaction | Texas AG GOP Primary + Border, Crime, AI Fraud

Feb 18, 2026 ·146m

Epstein Files: What the Newly Released DOJ Documents Actually Reveal (and What They Don’t) | LIVE

Feb 17, 2026 ·107m

Successful Companies Don’t Die Of Competition; They Die Of Confusion, Inconsistency, And Disengagement

Feb 16, 2026 ·37m

TRUMP From the White House: Champion of Coal Event (Watch + Real-Time Analysis)

Feb 12, 2026 ·55m

Similar Podcasts

She’s a Hazard to Herself She’s a Hazard Hi there, I’m Mallory, and I’d like to invite you into our world with “She’s a Hazard to Herself!” Join us as we navigate life with Multiple Sclerosis from the seat of my power wheelchair. Discover stories of resilience, family, and the community we’ve built around chronic illness. Whether you’re impacted by MS or want to learn from our journey, there’s something here for you. So why wait? Subscribe to “She’s a Hazard to Herself” on your favorite podcast app and be part of our journey today. Let’s lift each other up, one episode at a time! Growth Triggers Luis Diaz Discover how to use your podcast to generate leads, sales, and influence in any market.On this show Luis shares his best tested and proven secrets, tips, and strategies from launching over 300 podcasts in over a dozen different niches and generating over 59 Million Downloads for his clients.Learn how to increase your podcast listenership, create multiple new revenue streams with your podcast, sell more of your core offer and build a show that gives you leverage and authority in your space. From picking the right monetization strategy for your podcast to learning how to position your podcast in a crowded market on Apple and Spotify; this is show is the ultimate marketing and sales resource for online business owners who want to know what works with podcasting.Get in touch over on Instagram <a target="_blank" rel="noopener noreferrer nofollow" class="link" href="https://www.instagram.com/luisr Epic Real Estate Investing Matt Theriault In the spirit of Robert Kiyosaki’s Rich Dad Poor Dad and Gary Keller’s Millionaire Real Estate Investor, and as an alternate to the Dave Ramsey, Jim Cramer, Motley Fool and Suze Orman shows, Matt Theriault, real estate investor, entrepreneur and author will show you how to create wealth through conventional and creative real estate investing while improving your financial education so you will have the option to realistically retire in the next ten years, or less… and enjoy the good life while you’re still young enough to do so. This free podcast and course in real estate investing serves as a portal to multiple real estate investing courses making it a complete step-by-step and comprehensive real estate investing program and resource. The Brendan Ecker Influence Brendan Scott Ecker The Brendan Ecker Influence is hosted by Brendan Scott Ecker — a 27-year-old American entrepreneur, Michigan real estate agent, CEO of Gold Shark Media Ai, founder of PassRE USA, investor, law enforcement officer, former NCAA two-sport athlete, and author of Beyond the Beat and How I Made My Dorm My Office.Ecker went from a middle-class “Matrix” upbringing to building a fast-growing digital brand, scaling multiple businesses, and growing a YouTube channel with over 27,000 subscribers. With a background in Criminology, law enforcement, and competitive athletics, he blends discipline, strategy, and mindset into everything he teaches.On this podcast, Brendan breaks down the real frameworks behind wealth, business, real estate, marketing, AI, geopolitics, mindset, and personal growth. He discusses the journey in growing his businesses, documenting the wins, failures, and the tactical steps that helped him escape

Frequently Asked Questions

How long is this episode of Multiple Myeloma Hub?

This episode is 3 minutes long.

When was this Multiple Myeloma Hub episode published?

This episode was published on October 2, 2022.

What is this episode about?

During the 19th International Myeloma Society Annual Meeting, the Multiple Myeloma Hub was pleased to speak to Roman Hájek, University of Ostrava, Ostrava, CZ. We asked, Which patients might benefit the most from isatuximab-based combinations in the...

Can I download this Multiple Myeloma Hub episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!